Classical pathway complement activation on human endothelial cells

Molecular Immunology

Volumn 44, Issue 9, 2007, Pages 2228-2234

  Yin, Wei ^a   Ghebrehiwet, Berhane ^b   Weksler, Babette ^a   Peerschke, Ellinor I ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Classical pathway; Complement; gC1qR; Shear stress

Indexed keywords

CELL SURFACE IMMUNOGLOBULIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5B; COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PLASMA PROTEIN; PROTEIN; PROTEIN GC1QR; PROTEIN P33; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; COMPLEMENT ACTIVATION; COMPLEMENT FIXATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FLOW CYTOMETRY; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN CELL; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SERUM; SHEAR STRESS; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VASCULAR ENDOTHELIUM;

ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; COMPLEMENT PATHWAY, CLASSICAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; MITOCHONDRIAL PROTEINS; RATS; STRESS, MECHANICAL;

EID: 33846260264     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.11.012     Document Type: Article

References (34)

1. Acosta J., Qin X., and Halperin J. Complement and complement regulatory proteins as potential molecular targets for vascular diseases. Curr. Pharm. Des. 10 (2004) 203-211
2. Bhakdi S. Complement and atherogenesis: the unknown connection. Ann. Med. 30 (1998) 503-507
3. Botto M., and Walport M.J. C1q, autoimmunity and apoptosis. Immunobiology 205 (2002) 395-406
4. Dardik A., Chen L., Frattini J., Asada H., Aziz F., Kudo F.A., and Sumpio B.E. Differential effects of orbital and laminar shear stress on endothelial cells. J. Vasc. Surg. 41 (2005) 869-880
5. Devaraj S., Du Clos T.W., and Jialal I. Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1359-1363
6. Eggleton P., Tenner A.J., and Reid K.B. C1q receptors. Clin. Exp. Immunol. 120 (2000) 406-412
7. Fosbrink M., Niculescu F., and Rus H. The role of c5b-9 terminal complement complex in activation of the cell cycle and transcription. Immunol. Res. 31 (2005) 37-46
8. Ghebrehiwet B., and Peerschke E.I. cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol. Immunol. 41 (2004) 173-183
9. Ghebrehiwet B., Lu P.D., Zhang W., Lim B.L., Eggleton P., Leigh L.E., Reid K.B., and Peerschke E.I. Identification of functional domains on gC1Q-R, a cell surface protein that binds to the globular "heads" of C1Q, using monoclonal antibodies and synthetic peptides. Hybridoma 15 (1996) 333-342
10. Ghebrehiwet B., CebadaMora C., Tantral L., Jesty J., and Peerschke E.I. gC1qR/p33 serves as a molecular bridge between the complement and contact activation systems and is an important catalyst in inflammation. Adv. Exp. Med. Biol. 586 (2006) 95-105
11. Guo W.X., Ghebrehiwet B., Weksler B., Schweitzer K., and Peerschke E.I. Up-regulation of endothelial cell binding proteins/receptors for complement component C1q by inflammatory cytokines. J. Lab. Clin. Med. 133 (1999) 541-550
12. Huber-Lang M., Sarma J.V., Zetoune F.S., Rittirsch D., Neff T.A., McGuire S.R., Lambris J.D., Warner R.L., Flierl M.A., Hoesel L.M., Gebhard F., Younger J.G., Drouin S.M., Wetsel R.A., and Ward P.A. Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12 (2006) 682-687
13. Jagels M.A., Daffern P.J., and Hugli T.E. C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion. Immunopharmacology 46 (2000) 209-222
14. Joseph K., Tholanikunnel B.G., Ghebrehiwet B., and Kaplan A.P. Interaction of high molecular weight kininogen binding proteins on endothelial cells. Thromb. Haemost. 91 (2004) 61-70
15. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
16. Mahdi F., Madar Z.S., Figueroa C.D., and Schmaier A.H. Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes. Blood 99 (2002) 3585-3596
17. Nguyen T., Ghebrehiwet B., and Peerschke E.I. Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets. Infect. Immun. 68 (2000) 2061-2068
18. Niculescu F., and Rus H. Complement activation and atherosclerosis. Mol. Immunol. 36 (1999) 949-955
19. Niculescu F., Niculescu T., and Rus H. C5b-9 terminal complement complex assembly on apoptotic cells in human arterial wall with atherosclerosis. Exp. Mol. Pathol. 76 (2004) 17-23
20. Ogden C.A., and Elkon K.B. Role of complement and other innate immune mechanisms in the removal of apoptotic cells. Curr. Dir. Autoimmun. 9 (2006) 120-142
21. Peerschke E.I., and Ghebrehiwet B. Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis. Immunobiology 199 (1998) 239-249
22. Peerschke E.I., Smyth S.S., Teng E.I., Dalzell M., and Ghebrehiwet B. Human umbilical vein endothelial cells possess binding sites for the globular domain of C1q. J. Immunol. 157 (1996) 4154-4158
23. Peerschke E.I., Minta J.O., Zhou S.Z., Bini A., Gotlieb A., Colman R.W., and Ghebrehiwet B. Expression of gC1q-R/p33 and its major ligands in human atherosclerotic lesions. Mol. Immunol. 41 (2004) 759-766
24. Peerschke E.I., Yin W., Grigg S.E., and Ghebrehiwet B. Blood platelets activate the classical pathway of human complement. J. Thromb. Haemost. 4 (2006) 2035-2042
25. Reddigari S.R., Shibayama Y., Brunnee T., and Kaplan A.P. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. J. Biol. Chem. 268 (1993) 11982-11987
26. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
27. Saadi S., Holzknecht R.A., Patte C.P., and Platt J.L. Endothelial cell activation by pore-forming structures: pivotal role for interleukin-1 alpha. Circulation 101 (2000) 1867-1873
28. Schaiff W.T., and Eisenberg P.R. Direct induction of complement activation by pharmacologic activation of plasminogen. Coron. Artery Dis. 8 (1997) 9-18
29. Schweitzer K.M., Vicart P., Delouis C., Paulin D., Drager A.M., Langenhuijsen M.M., and Weksler B.B. Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. Lab. Invest. 76 (1997) 25-36
30. Speidl W.S., Exner M., Amighi J., Kastl S.P., Zorn G., Maurer G., Wagner O., Huber K., Minar E., Wojta J., and Schillinger M. Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis. Eur. Heart J. 26 (2005) 2294-2299
31. Tiong A.Y., and Brieger D. Inflammation and coronary artery disease. Am. Heart J. 150 (2005) 11-18
32. Torzewski J., Bowyer D.E., Waltenberger J., and Fitzsimmons C. Processes in atherogenesis: complement activation. Atherosclerosis 132 (1997) 131-138
33. Weksler B.B., Subileau E.A., Perriere N., Charneau P., Holloway K., Leveque M., Tricoire-Leignel H., Nicotra A., Bourdoulous S., Turowski P., Male D.K., Roux F., Greenwood J., Romero I.A., and Couraud P.O. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 19 (2005) 1872-1874
34. Yasojima K., Schwab C., McGeer E.G., and McGeer P.L. Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1214-1219